Single Use System in Biopharma Manufacturing Market, By Bioreactors (Less than 1000L, 1000-2000L, and More than 2000L), By Application (Filtration, Storage (Buffer & Media Storage, Freeze & Thaw), Cell Culture, Mixing, Purification, and Aseptic Filling), By Bioprocessing (Small-scale, Mid-scale, and Large-scale), By Product (Sampling Systems, Bioprocess Containers, Bioreactors, Mixers, Membrane Absorbers, Bottles, Equipment, Transfer Units, and Others (Disposable filter Cartridges (DFC), Depth Filters, Clamps etc.)), By Modality (Protein & Monoclonal Antibody (Mab), Cell Therapy, Gene Therapy, Conventional Vaccine, and mRNA), By Component (Drug Substance and Drug Product), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Sep 2022

Code : CMI5228

Pages :174

Formats :

Excel and PDF

Industry : Medical Devices

Single Use System In Biopharma Manufacturing MarketSize and Trends

The global single use system in biopharma manufacturing market was valued at US$ 7,030.0 Mn in 2021 and is forecast to reach value of US$ 26,450.3 Mn by 2028 at a CAGR of 20.8% between 2022 and 2028. The global single use system in biopharma manufacturing market is experiencing strong growth due to the increase in disease burden and increase in demand for drugs/vaccines across the globe. Moreover, rise in demand for biopharmaceutical products is expected to boost the growth of the market.

Figure 1. Global Single Use System in Biopharma Manufacturing Market Share (%), by Region, 2021

Based on Bioreactors, the market is segmented into less than 1000L, 1000-2000L, and More than 2000L. Out of which, All Segments are expected to dominate the global single use system in biopharma manufacturing market over the forecast period and this is attributed to the rise in demand for single use biopharmaceuticals across the globe.

Based on Application, the market is segmented into Filtration, Storage (Buffer & Media Storage, Freeze & Thaw), Cell Culture, Mixing, Purification, and Aseptic Filling. Out of which, Filtration Segment is expected to dominate the single use system in biopharma manufacturing market over the forecast period and this is attributed to the rise in usage of single-use filtration assemblies during biopharma manufacturing.

Cell Culture Segment is also expected to witness significant growth in the near future and this is owing to the ability of biopharmaceuticals to treat untreatable diseases. Cell culture is one of the major tools used in cellular and molecular biology, providing excellent model systems for studying the normal physiology and biochemistry of cells, effects of drugs & toxic compounds on the cells, and mutagenesis and carcinogenesis.

Based on Bioprocessing, the global single use system in biopharma manufacturing market is segmented into Small-scale, Mid-scale, and Large-scale. Of which, All Segment are expected to dominate the market over the forecast period and this is attributed to the increase in demand for biopharmaceutical products. Single-use bioprocessing is a rapidly evolving technology used in the development of disposable bioprocessing equipment and accessories to manufacture biopharmaceutical products.

Based on Product, the single use system in biopharma manufacturing market is segmented into Sampling Systems, Bioprocess Containers, Bioreactors, Mixers, Membrane Absorbers, Bottles, Equipment, Transfer Units, and Others (Disposable filter Cartridges (DFC), Depth Filters, Clamps, etc. Out of which, All Segments are expected to dominate the global single use system in biopharma manufacturing market over the forecast period and this is attributed to the increase in focus on the biopharma manufacturing.

Based on Modality, the market is segmented into Protein & Monoclonal Antibody (Mab), Cell Therapy, Gene Therapy, Conventional Vaccine, & mRNA. Of which, Protein & Monoclonal Antibody (Mab) Segment is expected to dominate the global single use system in biopharma manufacturing market over the forecast period and this is attributed to the rise in prevalence of chronic diseases. Monoclonal antibody drugs are treatments that enlist body's germ-fighting immune system against diseases, including cancer.

Gene Therapy Segment is also expected to witness significant growth in the near future and this is owing to the increase in disease burden. Gene therapy replaces the faulty gene or adds a new gene in an attempt to cure disease or improve the body's ability to fight disease.

Based on Component, the market is segmented into Drug Substance and Drug Product. Out of which, Both Segments are expected to dominate the global single use system in biopharma manufacturing market over the forecast period and this is attributed to the increase in demand for safe and effective drugs across the world. Single Use System offers a complete range of solutions for producing, scaling, and transporting drug substances or products.

Figure 2. Global Single Use System in Biopharma Manufacturing Market Share (%) in Terms of Value, by Bioreactor, 2021